{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T07:43:42Z","timestamp":1788248622241,"version":"build-2803163510"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.intimp.2022.109061","type":"journal-article","created":{"date-parts":[[2022,7,15]],"date-time":"2022-07-15T03:26:32Z","timestamp":1657855592000},"page":"109061","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"special_numbering":"C","title":["Autoimmune inflammatory rheumatic diseases post-COVID\u201019 vaccination"],"prefix":"10.1016","volume":"110","author":[{"given":"Azam","family":"Safary","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamal","family":"Esalatmanesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir Taher","family":"Eftekharsadat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad-Reza","family":"Jafari Nakjavani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alireza","family":"Khabbazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2022.109061_b0005","first-page":"1","article-title":"Micronutrient therapy and effective immune response: a promising approach for management of COVID-19","author":"Lotfi","year":"2021","journal-title":"Infection"},{"key":"10.1016\/j.intimp.2022.109061_b0010","first-page":"1","article-title":"Baricitinib combination therapy: a narrative review of repurposed Janus kinase inhibitor against severe SARS-CoV-2 infection","author":"Akbarzadeh-Khiavi","year":"2021","journal-title":"Infection"},{"issue":"3","key":"10.1016\/j.intimp.2022.109061_b0015","doi-asserted-by":"crossref","first-page":"205","DOI":"10.34172\/bi.2020.25","article-title":"Computational-based drug repurposing methods in COVID-19","volume":"10","author":"Masoudi-Sobhanzadeh","year":"2020","journal-title":"Bioimpacts"},{"issue":"2","key":"10.1016\/j.intimp.2022.109061_b0020","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.mehy.2007.04.043","article-title":"Acquired autoimmunity after viral vaccination is caused by molecular mimicry and antigen complimentarity in the presence of an immunologic adjuvant and specific HLA patterns","volume":"70","author":"Waisbren","year":"2008","journal-title":"Med. Hypotheses"},{"issue":"4","key":"10.1016\/j.intimp.2022.109061_b0025","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/imm.13443","article-title":"New-onset autoimmune phenomena post-COVID-19 vaccination","volume":"165","author":"Chen","year":"2022","journal-title":"Immunology"},{"key":"10.1016\/j.intimp.2022.109061_b0030","doi-asserted-by":"crossref","first-page":"100129","DOI":"10.1016\/j.jtauto.2021.100129","article-title":"Autoimmune rheumatic diseases: One or many diseases?","volume":"4","author":"Moutsopoulos","year":"2021","journal-title":"J. Transl. Autoimmun."},{"issue":"9894","key":"10.1016\/j.intimp.2022.109061_b0035","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S0140-6736(13)61499-3","article-title":"Clinical aspects of autoimmune rheumatic diseases","volume":"382","author":"Goldblatt","year":"2013","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.intimp.2022.109061_b0040","doi-asserted-by":"crossref","first-page":"94","DOI":"10.2174\/1871528114666160105113046","article-title":"Vaccination and Induction of Autoimmune Diseases","volume":"14","author":"Toussirot","year":"2015","journal-title":"Inflamm. Allergy Drug Targets"},{"issue":"3","key":"10.1016\/j.intimp.2022.109061_b0045","doi-asserted-by":"crossref","first-page":"247","DOI":"10.3109\/08830181003746304","article-title":"Could autoimmunity be induced by vaccination?","volume":"29","author":"Salemi","year":"2010","journal-title":"Int. Rev. Immunol."},{"issue":"2","key":"10.1016\/j.intimp.2022.109061_b0050","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.cvsm.2017.10.005","article-title":"Adverse reactions to vaccination: from anaphylaxis to autoimmunity","volume":"48","author":"Gershwin","year":"2018","journal-title":"Vet. Clin. North Am. Small Anim."},{"issue":"3","key":"10.1016\/j.intimp.2022.109061_b0055","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.kint.2021.06.033","article-title":"Granulomatous vasculitis after the AstraZeneca anti-SARS-CoV-2 vaccine","volume":"100","author":"Gillion","year":"2021","journal-title":"Kidney Int."},{"issue":"4","key":"10.1016\/j.intimp.2022.109061_b0060","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1053\/j.ajkd.2021.06.016","article-title":"ANCA-Associated Vasculitis Following Pfizer-BioNTech COVID-19 Vaccine","volume":"78","author":"Shakoor","year":"2021","journal-title":"Am. J. Kidney Dis."},{"issue":"8","key":"10.1016\/j.intimp.2022.109061_b0065","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1111\/ijd.15623","article-title":"Leukocytoclastic vasculitis flare following the COVID-19 vaccine","volume":"60","author":"Cohen","year":"2021","journal-title":"Int. J. Dermatol."},{"issue":"4","key":"10.1016\/j.intimp.2022.109061_b0070","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.kint.2021.07.026","article-title":"A case of ANCA-associated vasculitis after AZD1222 (Oxford-AstraZeneca) SARS-CoV-2 vaccination: casualty or causality?","volume":"100","author":"Villa","year":"2021","journal-title":"Kidney Int."},{"issue":"9","key":"10.1016\/j.intimp.2022.109061_b0075","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1093\/ndt\/gfab215","article-title":"Nephrotic syndrome and vasculitis following SARS-CoV-2 vaccine: true association or circumstantial?","volume":"36","author":"Izzedine","year":"2021","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.intimp.2022.109061_b0080","doi-asserted-by":"crossref","first-page":"107970","DOI":"10.1016\/j.intimp.2021.107970","article-title":"Autoimmune phenomena following SARS-CoV-2 vaccination","volume":"99","author":"Ishay","year":"2021","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2022.109061_b0085","first-page":"1","article-title":"Autoimmune post-COVID vaccine syndromes: does the spectrum of autoimmune\/inflammatory syndrome expand?","author":"Jara","year":"2022","journal-title":"Clin. Rheumatol."},{"issue":"11","key":"10.1016\/j.intimp.2022.109061_b0090","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1007\/s40266-019-00705-5","article-title":"Pathogenesis, Diagnosis and Management of Polymyalgia Rheumatica","volume":"36","author":"Camellino","year":"2019","journal-title":"Drugs Aging"},{"issue":"3","key":"10.1016\/j.intimp.2022.109061_b0095","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/s11926-021-00983-2","article-title":"Clinical Approach to Diagnosis and Therapy of Polyarteritis Nodosa","volume":"23","author":"Ho\u010devar","year":"2021","journal-title":"Curr. Rheumatol. Rep."},{"issue":"4","key":"10.1016\/j.intimp.2022.109061_b0100","doi-asserted-by":"crossref","first-page":"880","DOI":"10.3390\/cells9040880","article-title":"Update on the Pathomechanism, Diagnosis, and Treatment Options for Rheumatoid Arthritis","volume":"9","author":"Lin","year":"2020","journal-title":"Cells"},{"issue":"11","key":"10.1016\/j.intimp.2022.109061_b0105","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/s41584-019-0308-5","article-title":"Palindromic rheumatism as part of the rheumatoid arthritis continuum","volume":"15","author":"Mankia","year":"2019","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.intimp.2022.109061_b0110","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jaut.2018.07.018","article-title":"A comprehensive review on adult onset Still's disease","volume":"93","author":"Giacomelli","year":"2018","journal-title":"J. Autoimmun."},{"issue":"9","key":"10.1016\/j.intimp.2022.109061_b0115","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1136\/annrheumdis-2012-203165","article-title":"Drug therapy in undifferentiated arthritis: a systematic literature review","volume":"72","author":"Wevers-de Boer","year":"2013","journal-title":"Ann. Rheum. Dis."},{"issue":"11","key":"10.1016\/j.intimp.2022.109061_b0120","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.medcli.2020.05.009","article-title":"Systemic lupus erythematosus 2020","volume":"155","author":"Narv\u00e1ez","year":"2020","journal-title":"Med. Clin. (Barc)"},{"key":"10.1016\/j.intimp.2022.109061_b0125","doi-asserted-by":"crossref","first-page":"152012","DOI":"10.1016\/j.semarthrit.2022.152012","article-title":"What is peripheral spondyloarthritis? Identifying proportion, phenotype and burden in post hoc analysis of the ASAS-PerSpA study","volume":"55","author":"Ziade","year":"2022","journal-title":"Semin. Arthritis. Rheum."},{"key":"10.1016\/j.intimp.2022.109061_b0130","unstructured":"A.G. Andrew Steer, Acute rheumatic fever: Clinical manifestations and diagnosis, 2022. https:\/\/www.uptodate.com\/contents\/acute-rheumatic-fever-clinical-manifestations-and-diagnosis?search=acute-rheumatic-fever-clinical-manifestations-anddiagnosis&source=search_result&selectedTitle=1~92&usage_type=default&display_rank=1#H12. 2022)."},{"key":"10.1016\/j.intimp.2022.109061_b0135","unstructured":"A.v.T. David T Yu, Reactive arthritis, 2022. https:\/\/www.uptodate.com\/contents\/reactive-arthritis?search=reactive%20arthritis&source=search_result&selectedTitle=1~142&usage_type=default&display_rank=1."},{"issue":"4","key":"10.1016\/j.intimp.2022.109061_b0140","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1007\/s00296-021-05069-x","article-title":"ANCA-associated vasculitis following ChAdOx1 nCoV19 vaccination: case-based review","volume":"42","author":"Prabhahar","year":"2022","journal-title":"Rheumatol. Int."},{"issue":"8","key":"10.1016\/j.intimp.2022.109061_b0145","doi-asserted-by":"crossref","first-page":"815","DOI":"10.3390\/vaccines9080815","article-title":"Vaccinations and Autoimmune Diseases","volume":"9","author":"Olivieri","year":"2021","journal-title":"Vaccines (Basel)"},{"issue":"4","key":"10.1016\/j.intimp.2022.109061_b0150","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1002\/eji.201040466","article-title":"Bystander activation of CD4+ T cells","volume":"40","author":"Boyman","year":"2010","journal-title":"Eur. J. Immunol."},{"issue":"5","key":"10.1016\/j.intimp.2022.109061_b0155","doi-asserted-by":"crossref","first-page":"e0177365","DOI":"10.1371\/journal.pone.0177365","article-title":"Bystander activation of irrelevant CD4+ T cells following antigen-specific vaccination occurs in the presence and absence of adjuvant","volume":"12","author":"van Aalst","year":"2017","journal-title":"PLoS ONE"},{"key":"10.1016\/j.intimp.2022.109061_b0160","doi-asserted-by":"crossref","first-page":"102506","DOI":"10.1016\/j.jaut.2020.102506","article-title":"Autoinflammatory and autoimmune conditions at the crossroad of COVID-19","volume":"114","author":"Rodr\u00edguez","year":"2020","journal-title":"J. Autoimmun."},{"issue":"1","key":"10.1016\/j.intimp.2022.109061_b0165","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.intimp.2014.02.033","article-title":"Systemic immunotoxicity reactions induced by adjuvanted vaccines","volume":"20","author":"Batista-Duharte","year":"2014","journal-title":"Int. Immunopharmacol."},{"issue":"1","key":"10.1016\/j.intimp.2022.109061_b0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/jaut.1999.0346","article-title":"Vaccination and autoimmunity\u2014\u2018vaccinosis\u2019: a dangerous liaison?","volume":"14","author":"Shoenfeld","year":"2000","journal-title":"J. Autoimmun."},{"issue":"10293","key":"10.1016\/j.intimp.2022.109061_b0175","doi-asserted-by":"crossref","first-page":"e19","DOI":"10.1016\/S0140-6736(21)01238-1","article-title":"SARS-CoV-2 vaccine-induced immune thrombotic thrombocytopenia treated with immunoglobulin and argatroban","volume":"397","author":"Guetl","year":"2021","journal-title":"Lancet (London, England)"},{"issue":"7","key":"10.1016\/j.intimp.2022.109061_b0180","doi-asserted-by":"crossref","first-page":"e469","DOI":"10.1016\/S2665-9913(21)00108-9","article-title":"Flare of rheumatoid arthritis after COVID-19 vaccination","volume":"3","author":"Terracina","year":"2021","journal-title":"Lancet Rheumatol."},{"issue":"Pt B","key":"10.1016\/j.intimp.2022.109061_b0185","doi-asserted-by":"crossref","first-page":"108256","DOI":"10.1016\/j.intimp.2021.108256","article-title":"Arthritis following COVID-19 vaccination: report of two cases","volume":"101","author":"Unal Enginar","year":"2021","journal-title":"Int. Immunopharmacol."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576922005458?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576922005458?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T18:01:28Z","timestamp":1761588088000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576922005458"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":37,"alternative-id":["S1567576922005458"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2022.109061","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Autoimmune inflammatory rheumatic diseases post-COVID\u201019 vaccination","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2022.109061","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109061"}}